Ignite Creation Date:
2024-05-06 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04696042
Status:
RECRUITING
Last Update Posted:
2023-07-19
First Post:
2021-01-04
Brief Title:
Asian Investigation of Lanreotide Autogel in the Management of GEP-NETs
Sponsor:
Asan Medical Center
Organization:
Asan Medical Center
Study Overview
Official Title:
Prospective Observational Study to Assess the Effectiveness and Safety of Lanreotide Autogel in Patients With Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumors GEP-NETs in Asia Region
Status:
RECRUITING
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AIM-NETs
Brief Summary:
Lanreotide Autogel has been established as a standard of care for patients with locally advanced or metastatic GEP-NETs based on the success of CLARINET trial However only few patients with Asian ethnicity were included in the trial
According to the nationwide comprehensive study of patients with GEP-NET in Korea hindgut primary NETsRectal occured more frequently than western countries However small intestine or lung primary NET is relatively rare compared with western countries1 Considering the clinical characteristics of GEP-NETs are distinct between the patients in Asian and Western countries further evaluation on the efficacy and safety of Lanreotide Autogel in Asian patients with GEP-NETs is needed
According to the nationwide comprehensive study of patients with GEP-NET in Korea hindgut primary NETsRectal occured more frequently than western countries However small intestine or lung primary NET is relatively rare compared with western countries1 Considering the clinical characteristics of GEP-NETs are distinct between the patients in Asian and Western countries further evaluation on the efficacy and safety of Lanreotide Autogel in Asian patients with GEP-NETs is needed
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None